TICKERNERD
Menu
CMECMEFinancial Services · Financial Data & Stock Exchanges

CME Stock Forecast: CME Group, Inc. Price Predictions for 2026-2027

Last close, 23 Oct 2026
$306
−0.09% on the day

The 17 Wall Street analysts covering CME Group, Inc. hold a median 12-month price target of $325 — +6.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 84 of 100 as at 23 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$109.9B
Ticker Nerd rank
84/ 100
Median analyst target
$325
Analysts covering
17
Revenue$1.7B+0.8% y/y
Operating income$1.1B
Net income$1.0B
Free cash flow$923.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+4.0%
1M
+12.9%
YTD
+15.8%
1Y
+18.1%
From 52W high
−3.2%
From 52W low
+40.6%
$218
$316
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CME stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores CME Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 23 Oct 2026
84/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
95
Revisions
91
Quality
78
Momentum
73
Growth
72
Value
70
Issuance
68
Accruals
40
Size
2

Volatility (95): The share price has been relatively steady.

Accruals (40): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (2): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CME stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CME, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$200$250$300$350Jan 26Apr 26Jul 26Oct 26CMEHigh $367Median $325Low $227

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says17 analysts
9 Buy6 Hold2 Sell
Low $227Median $325High $367

The green dot is the last close — the median target sits +6.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 8 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
14 Oct 2026Wells FargoMaintainsOverweight$301 → $315
9 Oct 2026Morgan StanleyMaintainsOverweight$330 → $337
7 Oct 2026BarclaysMaintainsEqual-Weight$270 → $281
5 Oct 2026TD CowenMaintainsBuy$292 → $300
5 Oct 2026TD CowenMaintainsBuy—
5 Oct 2026UBSMaintainsNeutral—
5 Oct 2026UBSMaintainsNeutral$260 → $270
2 Oct 2026Wells FargoInitiatesOverweight—
2 Oct 2026Wells FargoInitiatesOverweight$301
28 Sept 2026TD CowenReiteratesBuy$292
28 Sept 2026TD CowenReiteratesBuy—
3 Sept 2026TD CowenReiteratesBuy$292
3 Sept 2026TD CowenReiteratesBuy—
19 Aug 2026Deutsche BankDowngradeHold—
19 Aug 2026Deutsche BankDowngradeHold$286 → $270
23 July 2026B of A SecuritiesMaintainsUnderperform$226 → $230
23 July 2026B of A SecuritiesMaintainsUnderperform—
23 July 2026JP MorganMaintainsUnderweight—
23 July 2026JP MorganMaintainsUnderweight$249 → $250
23 July 2026Morgan StanleyMaintainsOverweight$324 → $330

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

CME appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
  • The AI build-out, every Wednesday: how AI stocks did, part by part.

Free. Unsubscribe any time.

Performance

CME vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 23 Oct 2026, CME Group, Inc. returned +18.1% against +14.3% for the S&P 500, dividends included.

CME vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120Jan 26Apr 26Jul 26Oct 26CMES&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CME analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.2%
Analysts raising
8
Analysts cutting
2
Fundamentals

CME Group, Inc. (CME) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
25.1×

Cheaper than 30% of US stocks

Price / sales
15.8×

Cheaper than 10% of US stocks

Price / book
4.1×

Cheaper than 23% of US stocks

EV / EBITDA
22.3×

Cheaper than 12% of US stocks

Growth & margins
Revenue growth (YoY)
13.2%

Higher than 60% of US stocks

Earnings growth (YoY)
14.2%

Higher than 52% of US stocks

Gross margin
86.3%

Higher than 95% of US stocks

Operating margin
65.7%

Higher than 99% of US stocks

Net margin
63.5%

Higher than 97% of US stocks

Returns & dividend
Return on equity
16.1%

Higher than 76% of US stocks

Return on assets
1.5%

Higher than 55% of US stocks

Dividend yield
1.7%

Higher than 77% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

CME Group, Inc. (CME) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • CME Group, Inc. has a market value of $109.9B and an enterprise value of $110.3B.

  • Revenue in the twelve months to 30 June 2026: $6.8B. The latest quarter grew 13.2% year on year.

  • Net income over the same four quarters: $4.3B, a 63.3% net margin.

  • Diluted earnings per share, trailing twelve months: $11.79.

  • Free cash flow in the twelve months to 30 June 2026: $4.2B.

  • CME Group, Inc. spent $1.5B on share buybacks and $4.1B on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 359,275.

  • Trailing P/E: 25.1×; forward P/E: 23.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 1.70%, paying out 95% of earnings.

  • CME Group, Inc. employs 3,875 people — $1.7M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 24 Oct 2026

Data provided by Twelve Data

Peers

CME vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelFinancial Data & Stock Exchanges
CompanyMarket capTKN rank
CMECME Group, Inc.$109.9B84
ICEIntercontinental Exchange, Inc.$92.8B77
SPGIS&P Global, Inc.$132.8B51
MCOMoody's Corp.$86.2B63
NDAQNasdaq, Inc.$58.6B94
MSCIMSCI, Inc.$45.2B59
COINCoinbase Global, Inc.$43.4B6

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own CME Group, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CME news & analysis

CME Group's Results Were Solid, But Not Enough To Pull The Trigger On An Upgrade

Seeking Alpha · 22 Oct 2026neutral

CME Group reported Q3 revenue growth of 13% to $1.74 billion, with broad-based volume gains across product lines despite a slight decline in average rate per contract. Adjusted net profit margin was 62.4%, while the article says elevated valuation supports maintaining a hold rating.

Why it matters — CME watchers may weigh strong growth and low net debt against the valuation concern highlighted in the article.

What Will 100 Hyperliquid (HYPE) Be Worth by 2030?

24/7 Wall Street · 21 Oct 2026neutral

The article highlights Multicoin Capital making Hyperliquid its largest hedge fund position and a fee-based mechanism that purchases HYPE daily.

Why it matters — The item concerns activity around a digital-asset platform, offering CME watchers context on developments in the broader crypto market.

CME CEO Terry Duffy: We're seeing a record-level of participation

CNBC Television · 21 Oct 2026positive

CME Group CEO Terry Duffy discussed record Q3 revenue, the future of trading, and what he described as record-level participation in an interview with CNBC’s “Power Lunch.”

Why it matters — The interview highlights company commentary on participation and revenue, as well as the direction of trading.

CME Group Inc. (CME) Q3 2026 Earnings Call Transcript

Seeking Alpha · 21 Oct 2026neutral

Seeking Alpha published a transcript of CME Group Inc.’s Q3 2026 earnings call. The excerpt provides no details from the call.

Why it matters — CME watchers can note that a transcript is available, but the excerpt does not indicate what management discussed.

CME Group: 3 Key Takeaways for Long-Term Investors

The Motley Fool · 21 Oct 2026positive

CME Group reported average daily volume of 29.4 million contracts in the third quarter and provided clients with an average of $100 billion in daily margin savings.

Why it matters — These figures highlight trading activity and the scale of margin savings CME provided to clients during the quarter.

FAQ

Frequently asked questions about CME stock

What is the CME stock price forecast for 2026-2027?

The 17 Wall Street analysts covering CME Group, Inc. have a median 12-month price target of $325, with estimates ranging from $227 to $367. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CME stock a buy right now?

Of the 17 analysts covering CME Group, Inc., 9 rate it a Buy, 6 a Hold and 2 a Sell. Ticker Nerd's systematic factor model ranks CME Group, Inc. 84 out of 100 across roughly 4,600 US stocks as at 23 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CME?

As at 23 Oct 2026, CME Group, Inc. ranks 84 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (95 of 100).

Will CME stock go up?

No one can know that. What the data says: the median 12-month target from 17 analysts implies +6.1% from the last close, and Ticker Nerd's factor model ranks CME Group, Inc. 84 out of 100 as at 23 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CME stock forecast for 2030?

No analyst covering CME Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CME are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $227 to $367 over the next 12 months.

How has CME stock performed over the past year?

CME Group, Inc. returned +18.1% over the 12 months to 23 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does CME Group, Inc. do?

CME Group Inc. Class A Common Stock represents ownership in CME Group, a leading global marketplace for derivatives trading and market data services.

What is the latest news on CME?

The most recent item we track (Seeking Alpha, 22 Oct 2026): "CME Group's Results Were Solid, But Not Enough To Pull The Trigger On An Upgrade". CME Group reported Q3 revenue growth of 13% to $1.74 billion, with broad-based volume gains across product lines despite a slight decline in average rate per contract. Adjusted net profit margin was 62.4%, while the article says elevated valuation supports maintaining a hold rating.

Company

About CME Group, Inc.

CME Group Inc. Class A Common Stock represents ownership in CME Group, a leading global marketplace for derivatives trading and market data services. CME Group operates a broad range of futures and options contracts across major asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals. Its core businesses also include clearing, settlement, and related market infrastructure that support risk management and price discovery for institutional investors, commercial hedgers, brokers, and other market participants. The company’s exchange and clearing services are widely used by financial firms and corporate users seeking efficient access to standardized, centrally cleared contracts. CME Group Inc. is headquartered in Chicago and is known for its diversified role in global financial markets, where its products help facilitate trading, hedging, and liquidity across multiple asset classes.

CEO Mr. Terrence A. Duffy · 3,875 employees · United States · https://www.cmegroup.com